Services on Demand
- Cited by SciELO
- Access statistics
- Cited by Google
- Similars in SciELO
- Similars in Google
Print version ISSN 0034-7094
Rev. Bras. Anestesiol. vol.59 no.1 Campinas Jan./Feb. 2009
Impact of induced cardiac arrest on cognitive function after implantation of a cardioverter-defibrillator*
Impacto de la parada cardíaca inducida en las funciones cognitivas después del implante de desfibrilador cardiaco
Mauro Prado da Silva, TSA, M.D.I; Luiz Antonio Rivetti, M.D.II; Lígia Andrade Silva Telles Mathias, TSA, M.D.III; Guilherme Cagno, M.D.IV; Christiano Matsui, M.D.V
Assistente do Serviço e Disciplina de Anestesiologia da SCMSP; Mestrado
em Medicina pela FCM/SCMSP
IIProfessor Adjunto do Departamento de Cirurgia da FCM/SCMSP; Chefe da Disciplina de Cirurgia Cardíaca da SCMSP
IIIProfessora Adjunta da FCM/SCMSP; Diretora do Serviço de Anestesiologia e Dor da Santa Casa de São Paulo; Responsável pelo CET/SBA da SCMSP
IVAluno do sexto ano de Medicina da FCM/SCMSP
VME3 do CET/SBA da SCMSP
OBJECTIVES: Implantable cardioverter-defibrillators (ICD) were introduced
in clinical practice in 1980 and they are considered the standard treatment
for individuals at risk for fatal ventricular arrhythmias. To ensure proper
working conditions, the energy necessary to interrupt ventricular tachycardia
or ventricular fibrillation should be determined during implantation by a test
called defibrillation threshold. For this test, it is necessary to induce ventricular
fibrillation, which should be identified and treated by the device. The objective
of the present study was to determine the frequency of cognitive dysfunction
24 hours after the implantation of a cardioverter-defibrillator.
METHODS: Thirty consecutive patients with indication of cardioverter-defibrillator (ICD) placement and 30 patients with indication of implantable pacemaker (PM) were enrolled in this study. Patients were evaluated at the following moments: 24 hours before placement of the ICD or PM with a pre-anesthetic evaluation form, Mini Mental State Examination (MMSE), and Confusion Assessment Method (CAM); during implantation of the ICD or PM, the following parameters were determined: number of cardiac arrests and total time of cardiac arrest. Twenty-four hours after placement of the device, the following parameters were evaluated: MMSE and CAM.
RESULTS: Differences in the frequency of altered MMSE and CAM scores between both groups before and after implantation were not detected by the Fisher Exact test. The mean time of cardiac arrest was 7.06 seconds, with a maximal of 15.1 and minimal of 4.7 seconds.
CONCLUSIONS: Induction of cardiac arrest during defibrillation threshold testing did not cause cognitive dysfunction 24 hours after implantation of the cardioverter-defibrillator.
Key Words: COMPLICATIONS: brain ischemia, neurologic manifestations, cognitive dysfunction; EQUIPMENT: implantable defibrillators; pacemaker; SURGERY, Cardiac: induced cardiac arrest.
Y OBJETIVOS: El desfibrilador cardiaco implantable (DCI) fue introducido
en la práctica clínica en el 1980 y se considera el tratamiento
estándar para individuos bajo el riesgo de desarrollar arritmias ventriculares
fatales. Con el interés de garantizar el funcionamiento adecuado del
desfibrilador cardiaco, la energía necesaria para el término de
la taquicardia ventricular o de la fibrilación ventricular, debe ser
determinada durante el implante, siendo este procedimiento llamado test del
límite de desfibrilación. Para la realización del test
es necesario que se haga la inducción de la fibrilación ventricular,
para que el aparato pueda identificar el ritmo cardíaco y tratarlo. El
objetivo de este estudio fue verificar la incidencia de disfunción cognitiva
24 horas después del implante del desfibrilador cardiaco.
MÉTODO: Se seleccionó una muestra consecutiva de 30 pacientes con indicación de colocación de desfibrilador cardiaco implantable (DCI) y 30 pacientes con indicación de implante de marca-paso (MP). Los pacientes fueron evaluados en los siguientes momentos: 24 horas antes de la colocación del DCI o MP con ficha de evaluación preanestésica, Mini-Examen del Estado Mental (MEEM) y Confusion Assessment Method (CAM). Durante el implante del DCI o MP fueron medidas las variables: número de paradas cardíacas y tiempo total de parada cardíaca. Veinte y cuatro horas después de la colocación del DCI o MP, se evaluaron las variables: MEEM y CAM.
RESULTADOS: El test de Fisher mostró que no había diferencia de la frecuencia de puntuaciones alteradas del MEEM y del CAM entre los grupos antes y después de los implantes. El tiempo promedio de PCR 7,06, con máximos y mínimos de 15,1 y 4,7 segundos.
CONCLUSIONES: La inducción de parada cardíaca durante el test del límite de desfibrilación, no conllevó a la disfunción cognitiva veinte y cuatro horas después del implante del desfibrilador cardiaco.
Sudden cardiac arrest is one of the main causes of deaths in occidental developed nations, with an incidence of 500,000/year, in the USA, and 400,000/year, in Europe 1.
The implantable cardioverter-defibrillator (ICD) was introduced in clinical practice in 1980, and it is considered the standard of care for individuals at risk for fatal ventricular arrhythmias 2. Several clinical studies have demonstrated its superiority in the prevention of sudden cardiac arrest when compared to pharmacological treatment 3-5.
To ensure the cardioverter-defibrillator works properly, the energy necessary to interrupt ventricular tachycardia or fibrillation should be determined during implantation, which is achieved by the fibrillation threshold test 6. The energy should be high enough to guarantee the return to normal rhythm, but low enough to preserve the battery and increase the durability of the implant 7. During this test, ventricular fibrillation is induced, and it should be identified and treated by the device 8. This procedure foresees the possible development of damage secondary to ischemia of high blood flow-dependent organs due to their high metabolic rate such as the brain 9,10.
Some studies used electroencephalographic monitoring, brain oxygen consumption, S-100 protein measurement, and neuron-specific enolase to detect the presence of changes in the brain after cardiac arrest induced during the defibrillation threshold test, but without correlating those changes with clinically detectable cognitive dysfunction 11-15.
Very few information on the risk factors for the development of postoperative cognitive dysfunction is available; however, elderly patients with multiple comorbidities seem to be at higher risk for neurologic and cognitive complications, besides those patients who needed cardiac surgery with extracorporeal circulation 16-18.
The medical literature on the development of cognitive dysfunction within 24 hours after the procedure in patients undergoing cardioverter-defibrillator implantation is very limited and controversial, and, due to the high personal, social, and economical cost of this complication, evaluating its presence in this population is necessary, and this was the objective of this study.
After approval by the Ethics on Research Committee of the Irmandade da Santa Casa de Misericórdia de São Paulo, 30 consecutive patients with indication of implantable cardioverter-defibrillator placement (GICD) and 30 patients with indication of pacemaker placement (GPM) from November 2006 to February 2007, were selected.
Patients with neurological and psychiatric disorders, hearing impairment, visual impairment, motor deficit of the upper limbs, and/or younger than 18 years were excluded.
Patients who agreed to participate in the study were evaluated on the following moments.
-Twenty-four hours before implantation of the cardioverter-defibrillator or pacemaker, when they answered the following forms: pre-anesthetic evaluation card; Mini Mental State Examination and Confusion Assessment Method.
-During implantation of the defibrillator-cardioverter or pacemaker, the following parameters were measured: number of cardiac arrests and total cardiac arrest time.
-Twenty-four hours after implantation of the cardioverter-defibrillator or pacemaker, when the following were evaluated: Mini-Mental State Examination and Confusion Assessment Method.
The size of the study population was calculated before collecting the data assuming a 30%-difference in the results of both groups, with an alpha error of 5% and beta error of 20%; therefore, 24 patients in each group would be necessary, but 30 patients were enrolled in each group to compensate for possible loss of follow-up.
Non-parametric Chi-square test was used to compare the schooling level. Fisher Exact test was used to compare gender and the scores at each assessment of cognitive function.
The Student t test for independent samples was used to compare continuous parameters with normal distribution. The study has a confidence interval of 95%, and a p < 0.05 was considered significant.
The statistical tests used in this study are included in the statistical package Sigma Stat for Windows, version 2.03, SPSS Inc.
Table I shows the anthropometric data and schooling of patients in both groups.
Statistical tests used to assess the homogeneity of GICD and GPM regarding gender, height, weight and schooling showed that both groups were comparable, but they were heterogeneous for age (Table I).
Table II shows the percentage of patients with altered Mini Mental State Examination (MMSE) and Confusion Assessment Method (CAM) scores 24 hours before and 24 hours after implantation if the defibrillator or pace-maker. Fisher Exact test did not show statistically significant differences in the frequency of altered MMSE scores between both groups in all three tests.
Twenty-four patients underwent one induction of ventricular fibrillation and six underwent two inductions.
Mean cardiorespiratory arrest time and respective standard deviation in patients in GICD were 7.06 and 3.61 seconds, with a maximal value of 15.1 sec and minimum of 4.7 sec.
Neuropsychological tests have been used postoperatively to establish the presence of cognitive dysfunction in patients undergoing cardiac surgeries 23-25.
In the present study, postoperative cognitive dysfunction (POCD) was defined as a 30% change of the mean obtained 24 hours before the implantation. For this, the Mini Mental State Examination (MMSE), which has been successful in screening for cognitive dysfunction, was used. The Confusion Assessment Method (CAM), developed to detect delirium, since this alteration can be easily mistaken by POCD, which would affect the results of the study, was also used. The use of both tests was validated in Brazil 20,22.
As for the anthropometric data, a significant increase in mean age was noted in the control group (GPM) when compared to the study group (GICD) (p < 0.0001), which could hinder assessment of the results, since elderly patients have a tendency for lower scores on neuropsychological tests 26. However, when comparing the results of those tests between both groups before implantation of the pacemaker or defibrillator, a significant difference was not detected (p < 0.05).
In the present study, most patients were subjected to one cardiac arrest. Murkin et al. 27 studied 14 patients with a mean of 12 episodes of induced ventricular fibrillation and found cognitive changes in 71% of the patients. Adams et al. 28 evaluated nine patients with a mean of 5.6 induced cardiac arrests and did not find any cognitive changes. Weigl et al. 29 evaluated 21 patients with a mean of three cardiac arrests and found some degree of postoperative cognitive dysfunction. Comparing those data, one can see that the incidence of cognitive dysfunction can increase with the increase in the number of induced cardiac arrests during implantation of the cardioverter-defibrillator.
Patients who have been successfully resuscitated after a cardiac arrest develop cognitive dysfunction that seems to be related with the delay in resuscitation maneuvers 30.
O'Reilly et al. 33 compared the cognitive function of patients who had an intra-hospital cardiac arrest and to whom the resuscitative maneuvers were instituted immediately, with patients that had extra-hospital cardiac arrest and, in both cases, they detected memory changes.
Although the present study detected the safety during the period of brain ischemia caused by the induction of ventricular fibrillation, this was probably due to the short duration of each episode of cardiac arrest imposed to the patients.
Techniques that allow prolonged ischemic periods in different situations with safety have been developed. Among them, the following, still experimental, are important: hypothermia 32, by reducing cellular metabolism; ischemic preconditioning, in which short periods of ischemia would prepare the intracellular structure for the subsequent ischemic event 33; and drugs that would protect the brain from ischemia and reperfusion 34.
Considering the study population and the method used, induction of cardiac arrest for up to 15.1 seconds during the defibrillation threshold test did not cause cognitive dysfunction 24 hours after the implantation of the cardioverter-defibrillator.
01. Trappe HJ, Wenzlaff P, Pfitzner P et al. Long-term follow up of patients with implantable cardiovertor-defibrillators and mild, moderate, or severe impairment of left ventricular function. Heart, 1997;78:243-249. [ Links ]
02. Cunningham AD, Plummer CJ, McComb JM et al. The implantable cardiovertor-defibrillator: postcode prescribing in the UK 1998-2002. Heart, 2005;91:1280-1283. [ Links ]
03. Koller MT, Schaer B, Wolbers M et al. Death without prior appropriate implantable cardiovertor-defibrillator therapy: a competing risk study. Circulation, 2008;117:1918-1926. [ Links ]
04. Rönn F, Kesek M, Höglund N et al. Long-term follow-up of patients treated with ICD: benefit in patients with preserved left ventricular function. Scand Cardiovasc J, 2008;42:125-129. [ Links ]
05. Thibodeau JB, Pillarisetti J, Khumri TM et al. Mortality rates and clinical predictors of reduced survival after cardiovertor-defibrillator implantation. Am J Cardiol, 2008;101:861-864. [ Links ]
06. Leong-Sit P, Gula LJ, Diamantouros P et al. Effect of defibrillation testing on management during implantable cardiovertor-defibrillator implantation. Am Heart J, 2006;152:1104-1108. [ Links ]
07. Schuger C, Ellenbogen KA, Faddis M et al. Defibrillation energy requirements in an ICD population receiving cardiac resynchronization therapy. J Cardiovasc Electrophysiol, 2006;17:247-250. [ Links ]
08. Pires LA, Johnson KM Intraoperative testing of the implantable cardiovertor-defibrillator: how much is enough? J Cardiovasc Electrophysiol, 2006;17:140-145. [ Links ]
09. Rao VL, Dogan A, Bowen KK et al. Traumatic injury to rat brain upregulates neuronal nitric oxide synthase expression and L-[3H]nitroarginine binding. J Neurotrauma, 1999;16:865-877. [ Links ]
10. Hattori K, Lee H, Hurn PD et al. Cognitive deficits after focal cerebral ischemia in mice. Stroke, 2000;31:1939-1944. [ Links ]
11. Dorman BH, Conroy JM, Baker JD et al. Cerebral monitoring during implantation of automatic internal cardiac defibrillators. South Med J, 1993;86:533-536. [ Links ]
12. Behrens S, Spies C, Neumann U et al. Cerebral ischemia during implantation of automatic defibrillators. Z Kardiol, 1995; 84:798-807. [ Links ]
13. Vriens EM, Bakker PF, Vries JW et al. The impact of repeated short episodes of circulatory arrest on cerebral function. Reassuring electroencephalographic (EEG) findings during defibrillation threshold testing at defibrillator implantation. Electroencephalogr Clin Neurophysiol, 1996;98:236-242. [ Links ]
14. Dworschak M, Franz M, Czerny M et al. Release of neuron-specific enolase and S100 after implantation of cardiovertors/defibrillators. Crit Care Med, 2003;31:2085-2089. [ Links ]
15. McNeill E, Gagnon RE, Potts JE et al. Cerebral oxygenation during defibrillator threshold testing of implantable cardiovertor-defibrillators. Pacing Clin Electrophysiol, 2005;28:528-533. [ Links ]
16. Dodds C, Allison J Postoperative cognitive deficit in the elderly surgical patient. Br J Anaesth, 1998;81:449-462. [ Links ]
17. Moller JT, Cluitmans P, Rasmussen LS et al. Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. Lancet. 1998;351:857-861. [ Links ]
18. Abildstrom H, Rasmussen LS, Rentowl P et al. Cognitive dysfunction 1-2 years after non-cardiac surgery in the elderly. Acta Anaesthesiol Scand, 2000;44:1246-1255. [ Links ]
19. Folstein MF, Folstein SE, McHugh PR "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198. [ Links ]
20. Bertolucci PH, Brucki SM, Campacci SR et al. The Mini-Mental State Examination in a general population: impact of educational status. Arq Neuropsiquiatr, 1994;52:1-7. [ Links ]
21. Inouye SK, van Dyck CH, Alessi CA et al. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med, 1990;113:941-948. [ Links ]
22. Fabbri RM, Moreira MA, Garrido R et al. Validity and reliability of the Portuguese version of the Confusion Assessment Method (CAM) for the detection of delirium in the elderly. Arq Neuropsiquiatr, 2001;59:175-179. [ Links ]
23. Savageau JA, Stanton BA, Jenkins CD et al. Neuropsychological dysfunction following elective cardiac operation. I. Early assessment. J Thorac Cardiovasc Surg, 1982;84:585-594. [ Links ]
24. Sotaniemi KA, Mononen H, Hokkanen TE Long-term cerebral outcome after open-heart surgery. A five-year neuropsychological follow-up study. Stroke, 1986;17:410-416. [ Links ]
25. Shaw PJ, Bates D, Cartlidge NE et al. An analysis of factors predisposing to neurological injury in patients undergoing coronary bypass operations. QJ Med, 1989;72:633-646. [ Links ]
26. Euser SM, Schram MT, Hofman A et al. Measuring cognitive function with age: the influence of selection by health and survival. Epidemiology, 2008;19:440-447 [ Links ]
27. Murkin JM, Baird DL, Martzke JS et al. Cognitive dysfunction after ventricular fibrillation during implantable cardiovertor/defibrillator procedures is related to duration of the reperfusion interval. Anesth Analg, 1997;84:1186-1192. [ Links ]
28. Adams DC, Heyer EJ, Emerson RG et al. Implantable cardiovertor-defibrillator. Evaluation of clinical neurologic outcome and electroencephalographic changes during implantation. J Thorac Cardiovasc Surg, 1995;109:565-573. [ Links ]
29. Weigl M, Moritz A, Steinlechner B et al. Neuronal injury after repeated brief cardiac arrests during internal cardiovertor-defibrillator implantation is associated with deterioration of cognitive function. Anesth Analg, 2006;103:403-409. [ Links ]
30. de Vos R, Koster RW, De Haan RJ et al. In-hospital cardiopulmonary resuscitation: prearrest morbidity and outcome. Arch Intern Med, 1999;159:845-850. [ Links ]
31. O'Reilly SM, Grubb NR, O'Carroll RE In-hospital cardiac arrest leads to chronic memory impairment. Resuscitation, 2003;58: 73-79. [ Links ]
32. Varon J, Acosta P Therapeutic hypothermia: past, present, and future. Chest, 2008;133:1267-1274. [ Links ]
33. Li J, Liu W, Ding S et al. Hyperbaric oxygen preconditioning induces tolerance against brain ischemia-reperfusion injury by upregulation of antioxidant enzymes in rats. Brain Res, 2008; 1210:223-229. [ Links ]
34. Zhao P, Peng L, Li L et al. Isoflurane preconditioning improves long-term neurologic outcome after hypoxic-ischemic brain injury in neonatal rats. Anesthesiology, 2007;107:963-970. [ Links ]
Correspondence to: Submitted em 5
de agosto de 2008 *
Received from Faculdade de Ciências Médicas da Santa Casa de Misericórdia
de São Paulo (FCM/SCMSP), São Paulo, SP
Dr. Mauro Prado da Silva
Rua Aureliano Coutinho 88/32 Higienópolis
01224-020 São Paulo, SP
Accepted para publicação em 27 de outubro de 2008
Submitted em 5
de agosto de 2008
* Received from Faculdade de Ciências Médicas da Santa Casa de Misericórdia de São Paulo (FCM/SCMSP), São Paulo, SP